BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 21712474)

  • 21. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
    de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
    J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updated overview of the Swedish Randomized Trials on Breast Cancer Screening with Mammography: age group 40-49 at randomization.
    Larsson LG; Andersson I; Bjurstam N; Fagerberg G; Frisell J; Tabár L; Nyström L
    J Natl Cancer Inst Monogr; 1997; (22):57-61. PubMed ID: 9709277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening.
    Tabar L; Yen MF; Vitak B; Chen HH; Smith RA; Duffy SW
    Lancet; 2003 Apr; 361(9367):1405-10. PubMed ID: 12727392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening.
    Chiu SY; Duffy S; Yen AM; Tabár L; Smith RA; Chen HH
    Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1219-28. PubMed ID: 20406961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.
    Tabar L; Fagerberg G; Chen HH; Duffy SW; Smart CR; Gad A; Smith RA
    Cancer; 1995 May; 75(10):2507-17. PubMed ID: 7736395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial.
    Nixon RM; Pharoah P; Tabar L; Krusemo UB; Duffy SW; Prevost TC; Chen HH
    Rev Epidemiol Sante Publique; 2000 Aug; 48(4):325-31. PubMed ID: 11011299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit.
    Tabar L; Fagerberg G; Duffy SW; Day NE
    J Epidemiol Community Health; 1989 Jun; 43(2):107-14. PubMed ID: 2512366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening.
    Yen AM; Duffy SW; Chen TH; Chen LS; Chiu SY; Fann JC; Wu WY; Su CW; Smith RA; Tabár L
    Cancer; 2012 Dec; 118(23):5728-32. PubMed ID: 22605639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer screening with mammography: overview of Swedish randomised trials.
    Nyström L; Rutqvist LE; Wall S; Lindgren A; Lindqvist M; Rydén S; Andersson I; Bjurstam N; Fagerberg G; Frisell J
    Lancet; 1993 Apr; 341(8851):973-8. PubMed ID: 8096941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation.
    Duffy SW; Tabar L; Vitak B; Yen MF; Warwick J; Smith RA; Chen HH
    Ann Oncol; 2003 Aug; 14(8):1196-8. PubMed ID: 12881376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare.
    Int J Cancer; 1996 Dec; 68(6):693-9. PubMed ID: 8980168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update of the Swedish Two-County Trial of breast cancer screening: histologic grade-specific and age-specific results.
    Tabar L; Vitak B; Chen HH; Prevost TC; Duffy SW
    Swiss Surg; 1999; 5(5):199-204. PubMed ID: 10546517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computer modelling of the Swedish two county trial of mammographic screening and trade offs between participation and screening interval.
    Fett MJ
    J Med Screen; 2001; 8(1):39-45. PubMed ID: 11373849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg.
    Nyström L; Bjurstam N; Jonsson H; Zackrisson S; Frisell J
    J Med Screen; 2017 Mar; 24(1):34-42. PubMed ID: 27306511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of radiation-induced breast cancers due to biennial mammographic screening in women aged 50-69 years is minimal.
    Hauge IH; Pedersen K; Olerud HM; Hole EO; Hofvind S
    Acta Radiol; 2014 Dec; 55(10):1174-9. PubMed ID: 24311702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years with a high or low risk of breast cancer: socioeconomic status, parity, and age at birth of first child.
    Hellquist BN; Czene K; Hjälm A; Nyström L; Jonsson H
    Cancer; 2015 Jan; 121(2):251-8. PubMed ID: 25242087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mammographic screening does not reduce breast cancer mortality].
    Sjönell G; Ståhle L
    Lakartidningen; 1999 Feb; 96(8):904-5, 908-13. PubMed ID: 10089737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammography in symptomatic and asymptomatic patients.
    Stomper PC; Gelman RS
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.